EARN - Ellington Credit Co

Insider Purchase by Simon Ronald I (Dir)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

5 months ago, Simon Ronald I, serving as Dir at Ellington Credit Co (EARN), purchased 10,536 shares at $5.68 per share, for a total transaction value of $59,843.00. Following this transaction, Simon Ronald I now holds 80,000 shares of EARN.

This purchase represents a 15.00% increase in Simon Ronald I's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, September 11, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, October 2, 2025, 21 days after the trade was made.

Ellington Credit Co operates in the FINANCIAL SERVICES sector, specifically within the ASSET MANAGEMENT industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Simon Ronald I

Dir

Ronald I. Simon (born 1938, age 86) is an independent trustee and Chair of the Nominating & Corporate Governance Committee at Ellington Credit Co (EARN), serving since May 2013.[[1]](https://fintool.com/app/research/companies/EFC/people/ronald-simon)[[3]](https://fintool.com/app/research/companies/EARN/people/ronald-simon)[[4]](https://simplywall.st/stocks/us/diversified-financials/nyse-earn/ellington-credit/management) He is a private investor and financial consultant with extensive experience in finance, health insurance, technology, and specialty finance across public companies.[[1]](https://fintool.com/app/research/companies/EFC/people/ronald-simon) Simon holds a B.A. from Harvard University, an M.A. from Columbia University, and a Ph.D. from Columbia Graduate School of Business.[[1]](https://fintool.com/app/research/companies/EFC/people/ronald-simon) His career highlights include prior directorships at American Independence Corp. (2002–2016), Independence Holdings Company (2016–2022, Audit Committee member), Collateral Therapeutics (1998–2002), Cardium Therapeutics (2006–2009), and roles such as CFO at Wingcast, LLC (2001–2002) and EVP & CFO at Western Water Company (1997–2000).[[1]](https://fintool.com/app/research/companies/EFC/people/ronald-simon) He also serves as an independent director and Chairman of the Board (since 2021) and Audit Committee Chair at Ellington Financial Inc. (EFC), with board service since 2007, and owns shares in both EARN and EFC.[[1]](https://fintool.com/app/research/companies/EFC/people/ronald-simon)[[2]](https://www.gurufocus.com/insider/85902/ronald-i-simon) Recognized as an audit committee financial expert under SEC rules, Simon provides strong oversight in financial reporting and governance.[[1]](https://fintool.com/app/research/companies/EFC/people/ronald-simon)

View full insider profile →

Trade Price

$5.68

Quantity

10,536

Total Value

$59,843.00

Shares Owned

80,000

Trade Date

Thursday, September 11, 2025

163 days ago

SEC Filing Date

Thursday, October 2, 2025

Filed 21 days after trade

FINANCIAL SERVICESASSET MANAGEMENT

About Ellington Credit Co

Company Overview

No company information available
View news mentioning EARN

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/591421

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime